Larvol Delta - Coya-Therapeutics-Announces-Conference-Call-to-Report-Results-from-an-InvestigatorInitiated-Phase-2-Trial-of-LowDose-Interleukin2-in-Patients-with-Mild-to-Moderate-Alzheimers-Disease

COYA 301 - Coya Therap

https://www.businesswire.com/news/home/20241028411053/en/Coya-Therapeutics-Announces-Conference-Call-to-Report-Results-from-an-Investigator-Initiated-Phase-2-Trial-of-Low-Dose-Interleukin-2-in-Patients-with-Mild-to-Moderate-Alzheimer%E2%80%99s-Disease

Oct 28, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next